Publisher： Adis International
ISSN： 1174-5886
Source： Drugs in R&D, Vol.10, Iss.3, 2010-09, pp. : 179-202
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Telaprevir for the treatment of hepatitis C
By Forestier Nicole Zeuzem Stefan
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. :
Access to resources
Recommend
Telaprevir influences ciclosporin, tacrolimus pharmacokinetics
Reactions Weekly, Vol. 1, Iss. 1354, 2011-01 ,pp. :
Canada funds denosumab, telaprevir and rivaroxaban
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 653, 2012-01 ,pp. :
Updated revenue forecasts for telaprevir and boceprevir
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 629, 2011-01 ,pp. :
Telaprevir vs boceprevir: no clear winner
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :